---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-006545"
form_type: "8-K"
ticker: "BCRX"
cik: "0000882796"
company_name: "BIOCRYST PHARMACEUTICALS INC"
filed_at: "2021-09-20T23:59:59+00:00"
generated_at: "2026-06-29T02:48:48.302904+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioCryst appoints former FDA deputy center director Dr. Amy McKee to board of directors

## Summary
- Board expanded from 10 to 11 members; Dr. McKee elected effective September 20, 2021.
- Dr. McKee served as Deputy Center Director for FDA's Oncology Center of Excellence and is now VP at Parexel.
- Dr. McKee to serve on Science Committee; receives initial grant of 53,333 stock options plus annual grants of 40,000 options.
- Appointment brings regulatory expertise as BioCryst advances BCX9930 into pivotal trials for PNH and other complement diseases.

## SEC filing metadata
- accession: 0001171843-21-006545
- form_type: 8-K
- ticker: BCRX
- cik: 0000882796
- company_name: BIOCRYST PHARMACEUTICALS INC
- filed_at: 2021-09-20T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882796/000117184321006545/0001171843-21-006545-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882796/000117184321006545/f8k_092021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-006545
- JSON: https://secwatch.observer/filing/0001171843-21-006545.json
- Plain text: https://secwatch.observer/filing/0001171843-21-006545.txt

## Key facts
- Executive change
  Amy McKee was elected as Director at BIOCRYST PHARMACEUTICALS INC.
  - Action: elected
  - Role: Director
  source text: elected Amy McKee, M.D. to fill the vacancy created by the enlargement of the Board, effective September 20, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/882796/000117184321006545/0001171843-21-006545-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.